Applications of human tissue-engineered blood vessel models to study the effects of shed membrane microparticles from T-lymphocytes on vascular function.
D001808:Blood Vessels / Q000378:metabolism / Q000502:physiology; D002462:Cell Membrane / Q000378:metabolism*; D002478:Cells, Cultured; D051546:Cyclooxygenase 2 / Q000378:metabolism; D004730:Endothelium, Vascular / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D005347:Fibroblasts / Q000378:metabolism; D019084:Fluorescent Antibody Technique, Indirect; D006632:Histamine / Q000494:pharmacology; D006801:Humans; D032389:Myocytes, Smooth Muscle / Q000378:metabolism; D016328:NF-kappa B / Q000378:metabolism; D009569:Nitric Oxide / Q000096:biosynthesis; D052247:Nitric Oxide Synthase Type II / Q000378:metabolism; D010316:Particle Size; D013481:Superoxides / Q000378:metabolism; D013601:T-Lymphocytes / Q000187:drug effects / Q000378:metabolism*; D023822:Tissue Engineering / Q000379:methods; D017540:Tunica Media / Q000378:metabolism / Q000502:physiology; D014469:Umbilical Arteries / Q000166:cytology / Q000378:metabolism; D014470:Umbilical Cord / Q000166:cytology
D016328:NF-kappa B; D013481:Superoxides; D009569:Nitric Oxide; D006632:Histamine; D052247:Nitric Oxide Synthase Type II; D051546:Cyclooxygenase 2